Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Theratechnologies Inc (NQ: THTX )

1.200 -0.010 (-0.83%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theratechnologies Inc

< Previous 1 2 3 4 5 6 Next >
Earnings Outlook For Theratechnologies
Via Benzinga
Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
From Theratechnologies
Via GlobeNewswire
Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review
From Theratechnologies
Via GlobeNewswire
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
From Theratechnologies
Via GlobeNewswire
Theratechnologies Earnings Preview
Via Benzinga
Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update
From Theratechnologies
Via GlobeNewswire
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics. 
Via Benzinga
Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Theratechnologies
Via GlobeNewswire
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're diving into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! 
Via InvestorPlace
Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple... 
Via Benzinga
Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights
From Theratechnologies
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 57 companies reached new 52-week lows. 
Via Benzinga
Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide
From Theratechnologies
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 210 companies reached new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 27 stocks hit new 52-week lows. 
Via Benzinga
Theratechnologies Completes 1-for-4 Reverse Stock Split
From Theratechnologies
Via GlobeNewswire
Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management
From Theratechnologies
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
Theratechnologies Announces the Resignation of One of Its Directors, Mr. Gary Littlejohn
From Theratechnologies
Via GlobeNewswire
Theratechnologies Announces 1-for-4 Reverse Stock Split
From Theratechnologies
Via GlobeNewswire
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected
U.S. stocks traded higher midway through trading, with the S&P 500 gaining 1% on Wednesday. The Dow traded up 0.84% to 34,550.13 while the NASDAQ rose 1.32% to 13,941.87. The S&P 500, also rose,... 
Via Benzinga
Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates
From Theratechnologies
Via GlobeNewswire
Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update
From Theratechnologies
Via GlobeNewswire
Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management
From Theratechnologies
Via GlobeNewswire
Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial
From Theratechnologies
Via GlobeNewswire
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
From Theratechnologies
Via GlobeNewswire
Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023
From Theratechnologies
Via GlobeNewswire
Theratechnologies Reports on its Annual Meeting of Shareholders
From Theratechnologies
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.